PLENARY 3: Novel Pro-Resolving Mediators in Infectious Inflammation & Tissue Regeneration
May
29
8:45 AM08:45

PLENARY 3: Novel Pro-Resolving Mediators in Infectious Inflammation & Tissue Regeneration

Prof. Charles N. Serhan, Ph.D., D.Sc.
Harvard Medical School

United States of America

Charles is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School, Professor of Oral Medicine, Infection and Immunity at HSDM, and Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. He received a BS in biochemistry from Stony Brook University followed by a doctorate in experimental pathology and medical sciences from New York University School of Medicine. He was a visiting scientist and post-doctoral fellow at the Karolinska Institutet, Stockholm with Professor Bengt Samuelsson 1982 Nobel Laureate. In 1987, he joined the faculty at Harvard Medical School and received an honorary degree from Harvard University (1996).

He has received several awards including an NIH MERIT award (2000) and has delivered > 50 keynote and plenary lectures.  Among these, 2008 William Harvey Outstanding Scientist Medal and AAAS Fellow in 2011. In 2010, he received the Society for Leukocyte Biology-Bonazinga Award, American College of Rheumatology Hench Award Lecture in 2011, and Mérieux 2013 Laureate. In 2016, he received the IUBMB Lecture Metal and the Ross Prize in Molecular Medicine. 2017 Lifetime Achievement Award, International Eicosanoid Research Foundation.

http://research.bwhanesthesia.org/research-groups/cetri/serhan-lab

MyBibliography > 530 publications original reports and reviews. Professor Serhan is author of 4 books, and > 463 US patents.  H-index: 125; Citations: 55,987. i10 index: 425 (09/15/16).

View Event →
PLENARY 4: Beyond GWAS of insulin resistance: translation of genetic association to function
May
29
1:15 PM13:15

PLENARY 4: Beyond GWAS of insulin resistance: translation of genetic association to function

Prof. Erik Ingelsson
Stanford University

United States of America

Dr. Ingelsson obtained his MD (2000) and PhD (2005) at Uppsala University, Sweden. After internship, he did a residency in general medicine (2003-2006) and took up a postdoctoral research fellowship at the Framingham Heart Study (2006-2007). He moved to Karolinska Institutet (Stockholm, Sweden) in 2007 and was appointed Professor of Cardiovascular Epidemiology in 2010. From 2013-2016, he was a Professor of Molecular Epidemiology at Uppsala University. He was also a Visiting Professor at the Wellcome Trust Centre for Human Genetics at University of Oxford in 2012-2015. Since May 2016, he is Professor of Medicine at Stanford University.

His main area of interest is the link between metabolic disturbances, such as obesity and insulin resistance, and the development of subclinical and clinical cardiovascular disease. His research is translational and interdisciplinary, combining methods from the molecular epidemiology field - such as genomic, metabolomic, transcriptomic, epigenomic and proteomic profiling in large population-based studies - with in vivo and in vitro work to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel targets for drug development.

He has had a leading role in many of the large efforts identifying new loci associated with cardiovascular and metabolic traits, and has extensive experience from research on biomarkers and -omics methods, including development and use of prediction metrics and Mendelian randomization. He has served as PI of numerous –omics efforts in several Swedish cohort studies, including ULSAM, PIVUS, TwinGene and EpiHealth. Since 2014 and on, he has also built a team working with characterization of loci established in GWAS using different functional model systems. He has published over 230 peer-reviewed publications, of which >50 in journals with impact factor over 30. Before relocating to the U.S, he received many European research grants, and now after joining the Stanford faculty in May 2016, he has received his my first NIH grants. He has won several prestigious awards and grants, such as the AHA Trudy Bush Fellowship for Cardiovascular Research in Women’s Health, ERC starting grant, Wallenberg Academy Fellow and the Göran Gustafsson Prize in Medicine in 2015 (to the most successful medical researcher in Sweden under age 45).

On his spare time, he likes to spend time with his family (wife Maria, Hugo, 12 and Alice, 10 years old) and friends; enjoys cooking, but also eating nice food and wine; tries to make his daily running routine; and sings in choirs - amongst others, the San Francisco Symphony Chorus.

View Event →
May
29
7:00 PM19:00

Special Interest Group Meetings

Special Interest Group Invitation

ISSFAL invites proposals for Special Interest Group meetings at the 2018 Biennial Congress in Las Vegas, May 27th – 31st.

This is an opportunity to have small group meetings on specialized topics for in-depth discussion, peer formation, particularly for younger generation professionals including students, and first-hand information sharing.  Lipid-related basic and clinical research topics are welcome.  Once the proposals are accepted, they will be posted on the web-page to attract participants.  Any interest group attracting at least 15 participants will be offered a meeting room with podium, AV equipment and desserts/refreshments on the evening of Tuesday May 29th starting at 7:00 PM.   

For initial evaluation, a one-paragraph proposal describing the background and justification should be submitted to the Congress Chair, Hee-Yong Kim at hykim@nih.gov

Hee-Yong Kim, Ph.D.
Chief, Laboratory of Molecular Signaling
NIAAA, NIH

View Event →